ALPHA 212 Trademark

Trademark Overview

On Wednesday, February 2, 2022, a trademark application was filed for ALPHA 212 with the United States Patent and Trademark Office. The USPTO has given the ALPHA 212 trademark a serial number of 79335533. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by AdvanCell Isotopes Pty Limited. The ALPHA 212 trademark is filed in the Pharmaceutical Products category with the following description:

Medical and pharmaceutical preparations for the treatment of cancer; medical and pharmaceutical preparations containing isotopes for the treatment of cancer; isotopes for medical purposes; radionuclides as radio isotopes for medical purposes
alpha 212

General Information

Serial Number79335533
Word MarkALPHA 212
Filing DateWednesday, February 2, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220384
Registration DateTuesday, November 21, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized wording "ALPHA 212" to the right of an irregular oval shape.
Goods and ServicesMedical and pharmaceutical preparations for the treatment of cancer; medical and pharmaceutical preparations containing isotopes for the treatment of cancer; isotopes for medical purposes; radionuclides as radio isotopes for medical purposes
Pseudo MarkALPHA TWO ONE TWO; ALPHA TWO HUNDRED TWELVE
Disclaimer with Predetermined Text"ALPHA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdvanCell Isotopes Pty Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameAdvanCell Isotopes Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameAdvanCell Isotopes Pty Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 21, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Monday, September 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Monday, January 23, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 23, 2023REFUSAL PROCESSED BY MPU
Thursday, November 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 16, 2022ASSIGNED TO EXAMINER
Tuesday, March 15, 2022APPLICATION FILING RECEIPT MAILED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

alpha medical isotopes purposes cancer pharmaceutical treatment preparations radio radionuclides containing